MRD / Regn No. : 20240001153 Date : 24/06/2026
Patient Name : Rupa Jaiswal Age & Gender : 50 Yrs. / Female
Contact No. : 9131676761 UHID :
Ht / Wt / BMI : 158 / 73.3 / 29.36 BP S / BP D : 129 / 75
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DM (18/Nov/2022) | DYSLIPIDEMIA (20/Nov/2024) | HYPERTENSION (20/Nov/2023) |
Subjective : TYPE 2 DM,CONTINUING SAME MEDICATIONS,11 KG WEIGHT GAIN
Objective : NONE
Analysis : TYPE 2 DM STABLE,DYSLIPIDEMIIA,DYSSMONIA,WEIGHT GAIN
Plan : INCREASE SEMAGLUTIDE 1 MG,SEE ME IN 2 MONTHS WITH TESTING  
Salient Investigations : FASTING PLASMA GLUCOSE (FPG): 92 mg/dL | POST PRANDIAL GLUCOSE (2HPP): 70 mg/dL
S# Generic (Trade) Name Route Dosage Usage Duration
1 ROSUVASTATIN 10 MG
ROSEDAY 10 MG
Medicine For CHOLESTEROL 		PO 0-0-1 AT BEDTIME
 TILL NEXT VISIT
MAY CAUSE FATIGUE AND MUSCLE PAIN
2 TELMISARTAN 40 MG
ERITEL 40 MG 		0-0-1 AT BEDTIME
 TILL NEXT VISIT
MAY CAUSE HIGH POTASSIUM
3 SGLT2I EMPAGLIFLOZIN 10 MG
JARDIANCE
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION 		PO 1-0-0 BEFORE FOOD
 TILL NEXT VISIT
MAY CAUSE GENITOURINARY INFECTIONS
4 INJECTION SEMAGLUTIDE 1 MG
OBEDA 1 MG
Medicine For DIABETES OBESITY 		SQ ONCE A WEEK AS DIRECTED NO RELATION TO FOOD
MAY CAUSE NAUSEA VOMITING AND VISUAL DISTURBANCE
       
Refill : 0 / Substitution:    
Education : RARE VERY RARE INSTANCES OF EYE DISTURBANCE WITH SEMAGLUTIDE HAVE BEEN REPORTED IF YOU HAVE AN EYE DISTURBANCE PLS INFORM US
Next Visit : 23/Aug/2026
Tests Suggested For Next Visit : FBS 2HPP HBA1C
   
   

Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu / 48748 HPRID: 71-0638-2075-7542

Disclaimer: This is an ONLINE consultation. The patient has not been physically examined. The prescription or advice is based on the patient's description of the problem which is given above and also explained over video consultation.
This is a Computer generated Prescription

Powered By: